Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
369.12
255.76
227.49
195.16
300.98
213.01
216.25
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
369.12
255.76
227.49
195.16
300.98
213.01
216.25
Raw Material Cost
15.75
22.99
23.21
22.35
25.13
20.97
20.12
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.19
0.19
0.22
0.16
0.28
0.30
0.32
Selling and Distribution Expenses
138.32
102.01
104.15
101.28
123.07
94.91
93.96
Other Expenses
2.67
2.37
2.41
2.55
2.20
2.40
2.59
Total Expenditure (Excl Depreciation)
180.94
148.87
151.68
149.33
170.47
140.22
140.28
Operating Profit (PBDIT) excl Other Income
188.2
106.89999999999999
75.8
45.8
130.5
72.8
76
Other Income
8.12
10.86
8.18
13.38
9.71
13.41
13.47
Operating Profit (PBDIT)
194.89
128.57
97.51
67.81
152.74
96.86
101.02
Interest
0.19
0.19
0.22
0.16
0.28
0.30
0.32
Exceptional Items
0.30
0.93
0.40
3.19
-0.79
-0.37
0.40
Gross Profit (PBDT)
353.37
232.77
204.28
172.80
275.86
192.03
196.13
Depreciation
0.00
13.52
13.52
13.67
13.67
12.87
12.87
Profit Before Tax
195.00
115.79
84.16
57.17
137.99
83.32
88.23
Tax
29.94
16.69
12.41
9.70
23.15
14.00
13.88
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
167.86
102.67
74.34
45.57
123.02
72.02
77.21
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
167.86
102.67
74.34
45.57
123.02
72.02
77.21
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.05
-3.79
-2.79
-3.73
-3.15
-3.32
-3.29
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
164.81
98.88
71.55
41.84
119.88
68.71
73.92
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,635.74
2,467.88
2,428.05
2,353.71
2,360.49
2,242.84
2,267.65
Earnings per share (EPS)
0.32
0.2
0.14
0.09
0.23
0.14
0.15
Diluted Earnings per share
0.32
0.2
0.14
0.09
0.23
0.14
0.15
Operating Profit Margin (Excl OI)
50.6%
40.74%
33.32%
20.88%
42.98%
33.14%
34.53%
Gross Profit Margin
52.83%
50.56%
42.94%
36.3%
50.39%
45.16%
46.75%
PAT Margin
45.47%
40.14%
32.68%
23.35%
40.87%
33.81%
35.7%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 22.62% vs 4.70% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 37.45% vs 1.52% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 30.63% vs -1.31% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -33.33% vs 0.00% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
369.12
0
369.12
Other Operating Income
0.00
0.00
0.00
Total Operating income
369.12
0
369.12
Raw Material Cost
15.75
0
15.75
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.19
0
0.19
Selling and Distribution Expenses
138.32
0
138.32
Other Expenses
2.67
0.00
2.67
Total Expenditure (Excl Depreciation)
180.94
0
180.94
Operating Profit (PBDIT) excl Other Income
188.18
0.00
188.18
Other Income
8.12
0
8.12
Operating Profit (PBDIT)
194.89
0
194.89
Interest
0.19
0
0.19
Exceptional Items
0.30
0
0.30
Gross Profit (PBDT)
353.37
0
353.37
Depreciation
0.00
0
0.00
Profit Before Tax
195.00
0
195.00
Tax
29.94
0
29.94
Provisions and contingencies
0
0
0.00
Profit After Tax
167.86
0
167.86
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
167.86
0
167.86
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.05
0
-3.05
Other related items
0.00
0.00
0.00
Consolidated Net Profit
164.81
0
164.81
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,635.74
0
2,635.74
Earnings per share (EPS)
0.32
0
0.32
Diluted Earnings per share
0.32
0
0.32
Operating Profit Margin (Excl OI)
50.60%
0%
0.00
50.60%
Gross Profit Margin
52.83%
0%
0.00
52.83%
PAT Margin
45.47%
0%
0.00
45.47%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 36.91 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 44.29% vs 12.44% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 22.62% vs 4.70% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 16.48 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 66.63% vs 38.13% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 37.45% vs 1.52% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.68 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 58.71% vs 31.80% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 30.63% vs -1.31% in Sep 2024
Quarterly - Interest
Interest 0.02 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -33.33% vs 0.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 50.60%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
